Verve Therapeutics (VERV) Insider Trading & Ownership

$6.91
+0.27 (+4.07%)
(As of 04/22/2024 ET)

Verve Therapeutics (NASDAQ:VERV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$18,818.66
Get VERV Insider Trade Alerts

Want to know when executives and insiders are buying or selling Verve Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VERV Insider Buying and Selling by Quarter

Verve Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/2/2024Joan NickersonInsiderSell1,514$8.24$12,475.36  
11/29/2023Allison DorvalCFOSell554$11.45$6,343.30  
(Data available from 1/1/2013 forward)

VERV Insider Trading Activity - Frequently Asked Questions

Who is on Verve Therapeutics's Insider Roster?

The list of insiders at Verve Therapeutics includes 2017 Gp L.L.C. Gv, Allison Dorval, Andrew Bellinger, Andrew D Ashe, Burt A Adelman, Fmr Llc, Joan Nickerson, Krishna Yeshwant, and Sekar Kathiresan. Learn more on insiders at VERV.

What percentage of Verve Therapeutics stock is owned by insiders?

21.40% of Verve Therapeutics stock is owned by insiders. Learn more on VERV's insider holdings.

Which Verve Therapeutics insiders have been buying company stock?

The following insider purchased VERV shares in the last 24 months: Burt A Adelman ($121,500.00).

How much insider buying is happening at Verve Therapeutics?

Insiders have purchased a total of 10,000 VERV shares in the last 24 months for a total of $121,500.00 bought.

Which Verve Therapeutics insiders have been selling company stock?

The following insiders have sold VERV shares in the last 24 months: 2017 Gp L.L.C. Gv ($9,234,884.58), Allison Dorval ($18,586.70), Andrew Bellinger ($3,486,251.75), Fmr Llc ($4,530,792.81), Joan Nickerson ($12,475.36), Krishna Yeshwant ($3,700,148.16), and Sekar Kathiresan ($4,672,500.00).

How much insider selling is happening at Verve Therapeutics?

Insiders have sold a total of 854,797 Verve Therapeutics shares in the last 24 months for a total of $25,655,639.36 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:VERV) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners